---
title: "Umary: Umary Acido Hialuronica, Suplemento Alimenticio – 30 Capletas de 850mg — FDA announcement Jul 15, 2024 | Is It on Recall"
description: "Tainted with the drug ingredients, diclofenac and omeprazole"
url: https://isitonrecall.com/recall/fdapress-c1ca28d072252a06-umary-umary-acido-hialuronica-suplemento-alimenticio-30-capletas-de-850mg/
updated: 2026-10-01
site: "Is It on Recall"
language: en
---

[Recall archive](https://isitonrecall.com/archives/) / FDA company announcement

# Umary: Umary Acido Hialuronica, Suplemento Alimenticio – 30 Capletas de 850mg — FDA announcement Jul 15, 2024

Published notice; closure not supplied

A company announcement posted by FDA. The listing date can differ from the original announcement date. The absence of a termination marker does not prove the recall is currently ongoing.

Source date Jul 15, 2024. Retrieved Oct 1, 2026. Last updated Oct 1, 2026.

Archive changed Oct 1, 2026. USDA FSIS records are unavailable; [check FSIS directly](https://www.fsis.usda.gov/recalls). [Source coverage and dates](https://isitonrecall.com/sources/).

## What the record says

- **Product**: Umary Acido Hialuronica, Suplemento Alimenticio – 30 Capletas de 850mg
- **Reason**: Tainted with the drug ingredients, diclofenac and omeprazole
- **Classification**: Not supplied
- **Recalling firm**: SoloVital.com
- **Quantity**: Not supplied
- **Agency-reported status**: Company recall announcement
- **Source record identifier**: c1ca28d072252a06

[Open the official record](https://www.fda.gov/safety/recalls-market-withdrawals-safety-alerts/solovitalcom-issues-voluntary-nationwide-recall-umary-acido-hialuronica-suplemento-alimenticio-850)

## Lot and product identifiers

| Label field | Details supplied by the agency |
| --- | --- |
| Lot, code or applicability | Not supplied |

Match all identifying details in the current notice. A brand name alone is not enough.

## Distribution

The product is used as a dietary supplement promoted and sold for pain and is packaged in bottles with 30 caplets. The affected product includes all lots within expiry. The product was distributed via online store at SoloVital.com

No US distribution state could be established from this record. Check the official notice.

## Dates in the source

- **Fda listing date**: Jul 15, 2024
- **Company announcement date**: Jul 15, 2024

FDA company pages use the listing date; enforcement records use initiation dates; CPSC uses recall date; NHTSA uses report-received date. These dates are not interchangeable.

## What to do next

Consumers with questions regarding this recall can contact SoloVital.com by e-mail info@solovital.com Mon. – Fri. 9am to 5pm PST, 24 to 48 hours response time. Consumers should contact their physician or healthcare provider if they have experienced any problems that may be related to taking or using this drug product.

[Read the current instructions](https://www.fda.gov/safety/recalls-market-withdrawals-safety-alerts/solovitalcom-issues-voluntary-nationwide-recall-umary-acido-hialuronica-suplemento-alimenticio-850)

## Before changing a medicine

Follow urgent instructions in the current official recall notice. Speak to your pharmacist or prescriber before stopping or changing a prescribed medicine.

Talk to your doctor or pharmacist if you have questions or concerns about your medicine. [FDA medication recall guidance](https://www.fda.gov/drugs/drug-recalls/understanding-drug-recalls-what-know-and-what-do)

## Related records

[Medications records](https://isitonrecall.com/category/medications/) [SoloVital.com records](https://isitonrecall.com/brand/solovital-com/)